Lisa F - Search Results

1

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk.

Osella-Abate S, Bertero L, Senetta R, Mariani S, Lisa F, Coppola V, Metovic J, Pasini B, Puig S S, Fierro MT, Manrique-Silva E, Kumar R, Nagore E, Cassoni P, Ribero S. Osella-Abate S, et al. Among authors: lisa f. Cancers (Basel). 2019 Mar 30;11(4):452. doi: 10.3390/cancers11040452. Cancers (Basel). 2019. PMID: 30934988 Free PMC article.

2

ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas.

Osella-Abate S, Mereu E, Pellegrino E, Bergaggio E, Ribero S, Bertero L, Lisa F, Fierro MT, Giulio Papotti M, Piva R. Osella-Abate S, et al. Among authors: lisa f. Oncol Lett. 2018 Dec;16(6):7091-7096. doi: 10.3892/ol.2018.9560. Epub 2018 Oct 9. Oncol Lett. 2018. PMID: 30546443 Free PMC article.

3

Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.

Novelli M, Fava P, Sarda C, Ponti R, Osella-Abate S, Savoia P, Bergallo M, Lisa F, Fierro MT, Quaglino P. Novelli M, et al. Among authors: lisa f. Am J Clin Pathol. 2015 Jan;143(1):57-69. doi: 10.1309/AJCP1NA3YCHCDEIG. Am J Clin Pathol. 2015. PMID: 25511143 Free article.

4

Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients.

Bernengo MG, Quaglino P, Cappello N, Lisa F, Osella-Abate S, Fierro MT. Bernengo MG, et al. Among authors: lisa f. Melanoma Res. 2000 Feb;10(1):55-65. Melanoma Res. 2000. PMID: 10711641

5

Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study.

Fierro MT, Lisa F, Novelli M, Bertero M, Bernengo MG. Fierro MT, et al. Among authors: lisa f. Dermatology. 1992;184(3):182-9. doi: 10.1159/000247537. Dermatology. 1992. PMID: 1392109

6

Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.

Bernengo MG, Quaglino P, Comessatti A, Ortoncelli M, Novelli M, Lisa F, Fierro MT. Bernengo MG, et al. Among authors: lisa f. Haematologica. 2007 Jun;92(6):784-94. doi: 10.3324/haematol.11127. Haematologica. 2007. PMID: 17550851 Free article. Clinical Trial.

7

Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.

Bernengo MG, Fierro MT, Novelli M, Lisa F, Appino A. Bernengo MG, et al. Among authors: lisa f. Br J Dermatol. 1993 Feb;128(2):124-9. doi: 10.1111/j.1365-2133.1993.tb15140.x. Br J Dermatol. 1993. PMID: 8457444

8

Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern.

Quaglino P, Osella-Abate S, Novelli M, Lisa F, Comessatti A, Bernengo MG. Quaglino P, et al. Among authors: lisa f. Eur J Dermatol. 2001 Nov-Dec;11(6):560-3. Eur J Dermatol. 2001. PMID: 11701409

9

Thymopentin in Sézary syndrome.

Bernengo MG, Appino A, Bertero M, Novelli M, Fierro MT, Doveil GC, Lisa F. Bernengo MG, et al. Among authors: lisa f. J Natl Cancer Inst. 1992 Sep 2;84(17):1341-6. doi: 10.1093/jnci/84.17.1341. J Natl Cancer Inst. 1992. PMID: 1386633

10

Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.

Bernengo MG, Quaglino P, Novelli M, Cappello N, Doveil GC, Lisa F, De Matteis A, Fierro MT, Appino A. Bernengo MG, et al. Among authors: lisa f. Ann Oncol. 1998 Aug;9(8):857-63. doi: 10.1023/a:1008397323199. Ann Oncol. 1998. PMID: 9789608 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters